期刊文献+

小儿肾脏疾病与脂质代谢紊乱临床探讨

Clinical Observation on Relationship between Renal Diseases in Children and Lipid Metabolism Disorder
下载PDF
导出
摘要 目的探讨小儿肾脏疾病与脂质代谢紊乱的关系。方法整群选取该院2014年8月—2015年9月肾病综合征患儿为观察组,选取同期正常的健康体检小儿为对照组。检测血清TC、TG、HDL-C、LDL-C、Apo A1与Apo B。结果观察组的TC为(10.42±3.68)、TG为(2.43±2.31)、HDL-C为(2.01±2.34)、LDL-C为(7.58±2.71)以及Apo B为(1.32±0.36),均高于对照组,组间比较有差异(P<0.05)。结论小儿肾脏疾病与脂质代谢紊乱之间存在密切的关系,脂质代谢紊乱是促肾小球硬化的一个高危因素,会造成患儿的肾功能出现进行性损害。 Objective To discuss the relationship between renal diseases in children and lipid metabolism disorder. Methods The children with nephrotic syndrome treated in our hospital from August 2014 to September 2015 were selected as the observation group, the normal children with healthy physical examination at the same period were selected as the control group, and the serum TC, TG, HDL-C, LDL-C, Apo A1 and Apo B were detected. Results The TC, TG, HDL-C, LDL-C and Apo B were respectively(10.42±3.68),(2.43±2.31),(2.01±2.34),(7.58±2.71) and(1.32±0.36), which were higher than those in the control group, and there were differences between groups by comparison(P〈0.05). Conclusion The renal diseases in children have a close relationship with lipid metabolism disorder, the lipid metabolism disorder is a high risk factor of glomerulosclerosis, and it can lead to progressive damage of the children's renal function.
作者 戴英侠
出处 《中外医疗》 2016年第8期48-49,共2页 China & Foreign Medical Treatment
关键词 小儿 肾脏疾病 脂质代谢紊乱 Children Renal diseases Lipid metabolism disorder
  • 相关文献

参考文献9

二级参考文献65

  • 1甘慧,杨军,孙萍,王全立.人类补体C3研究进展[J].国外医学(临床生物化学与检验学分册),2004,25(6):519-521. 被引量:26
  • 2沈锋,赵鸣武,贺蓓,王玉柱,姚婉贞.慢性阻塞性肺疾病和支气管哮喘患者诱导痰中白细胞介素-17水平及其意义[J].中华内科杂志,2004,43(12):888-890. 被引量:27
  • 3郝胜(综述),何威(审校),逊吴滢(审校).脂联素在肾脏疾病的研究进展[J].国际泌尿系统杂志,2007,27(1):100-104. 被引量:1
  • 4罗晓菊,刘雪梅,豆虎.急性肾小球肾炎与肾病综合征患儿体液免疫指标比较[J].实用儿科临床杂志,2007,22(5):363-364. 被引量:7
  • 5Yokota T,Oritani K,Takahashi I,et al.Adiponectin,a new member of the family of soluble defense collagens,negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages[J].Blood,2000,96(5):1723-1732.
  • 6Lam KS,Xu A.Adiponectin:protection of the endothe-lium[J].Curr Diab Rep,2005,5(4):254-259.
  • 7Zoccali C,Mallamaci F,Panuccio V,et al.Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors[J].Kidney Int Suppl,2003,(84):S98-S102.
  • 8Bakkaloglu SA,Soylemezoglu O,Buyan N,et al.High serum adiponectin levels during steroid-esponsive nephrotic syndrome relapse[J].Pediatr Nephrol,2005,20(4):474-477.
  • 9Zoccali C,Mallamaci F,Tripepi G,et al.Adiponectin,metabolic risk factors,and cardiovascular events among patients with end-stage renal disease[J].J Am Soc Nephrol,2002,13(1):134-141.
  • 10Ignacy W,Chudek J,Adamczak M,et al.Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease:a follow-up study[J].Nephron Clin Pract,2005,101(1):c18-c24.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部